Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2014 by Deutsches Herzzentrum Muenchen.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Deutsches Herzzentrum Muenchen Identifier:
First received: April 15, 2008
Last updated: October 8, 2014
Last verified: October 2014